Prasanth Ariyannur

ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Amrita Institute of Medical Sciences and Research Center, India

Dr Prasanth Ariyannur speaks about a Pilot Nanostring PanCancer Pathway analysis of Colon Adenocarcinoma in a tertiary healthcare centre in Kerala.

Dr Ariyannur gives a background to the need for more data on colon adenocarcinoma in Indian populations, as cases are higher than in western populations. He explains the methods used in their analysis and the significant genes that were identified, before going on to talk about what still needs to be investigated.

Dr Ariyannur concludes by discussing how the need for equality of analysis in specific populations across the world to better understand varying incidents of cancer, rather than relying on western data that may not represent the population well.

Read the full article here.

ecancermedicalscience

Prasanth Ariyannur

More from ecancer